CHASITY MCGANN: Open Payments
NPI 1720514383 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 32 payments from 19 companies in 2025. Trend: 2023 $203 · 2024 $94 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $74 |
| Amgen Inc. | 4 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| Lundbeck LLC | 2 | $52 |
| ARGENX US, INC. | 3 | $48 |
| SK Life Science, Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $34 |
| Eisai Inc. | 2 | $32 |
| LivaNova USA, Inc. | 1 | $26 |
Products named: PONVORY, UPLIZNA, VYEPTI, QULIPTA, VYVGART HYTRULO, INGREZZA, NURTEC ODT, Leqembi.
Industry payments across IN — which companies pay providers there.
